These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1429237)

  • 1. In vitro and in vivo antifungal activities of BMS-181184.
    Oki T; Kakushima M; Hirano M; Takahashi A; Ohta A; Masuyoshi S; Hatori M; Kamei H
    J Antibiot (Tokyo); 1992 Sep; 45(9):1512-7. PubMed ID: 1429237
    [No Abstract]   [Full Text] [Related]  

  • 2. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
    Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
    J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pradimicins T1 and T2, new antifungal antibiotics produced by an actinomycete. I. Taxonomy, production, isolation, physico-chemical and biological properties.
    Furumai T; Hasegawa T; Kakushima M; Suzuki K; Yamamoto H; Yamamoto S; Hirano M; Oki T
    J Antibiot (Tokyo); 1993 Apr; 46(4):589-97. PubMed ID: 8501001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
    Mitsuyama J; Nomura N; Hashimoto K; Yamada E; Nishikawa H; Kaeriyama M; Kimura A; Todo Y; Narita H
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1318-24. PubMed ID: 18227186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.
    Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Sato I; Furuta T; Tsurumi Y; Hori Y; Hino M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 2000 Sep; 53(9):920-7. PubMed ID: 11099225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
    Restrepo MI; Najvar LK; Fothergill AW; Graybill JR
    Med Mycol; 1998 Jun; 36(3):181-4. PubMed ID: 9776832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.
    Abruzzo GK; Flattery AM; Gill CJ; Kong L; Smith JG; Krupa D; Pikounis VB; Kropp H; Bartizal K
    Antimicrob Agents Chemother; 1995 May; 39(5):1077-81. PubMed ID: 7625792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Polak A; Scholer HJ; Wall M
    Chemotherapy; 1982; 28(6):461-79. PubMed ID: 6297858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Evaluation of Small Cationic Abiotic Lipopeptides as Novel Antifungal Agents.
    Lohan S; Monga J; Chauhan CS; Bisht GS
    Chem Biol Drug Des; 2015 Oct; 86(4):829-36. PubMed ID: 25777475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal and antiviral activities of benanomicins and their analogues.
    Kondo S; Gomi S; Ikeda D; Hamada M; Takeuchi T; Iwai H; Seki J; Hoshino H
    J Antibiot (Tokyo); 1991 Nov; 44(11):1228-36. PubMed ID: 1761419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with antifungal drugs.
    Polak A
    Mycoses; 1988; 31 Suppl 2():45-53. PubMed ID: 3067091
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antifungal activities of pradimicin A derivatives modification of the alanine moiety.
    Nishio M; Ohkuma H; Kakushima M; Ohta S; Iimura S; Hirano M; Konishi M; Oki T
    J Antibiot (Tokyo); 1993 Mar; 46(3):494-9. PubMed ID: 8478267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoses in AIDS patients.
    Dupont B; Denning DW; Marriott D; Sugar A; Viviani MA; Sirisanthana T
    J Med Vet Mycol; 1994; 32 Suppl 1():65-77. PubMed ID: 7722803
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative.
    Kakushima M; Masuyoshi S; Hirano M; Shinoda M; Ohta A; Kamei H; Oki T
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2185-90. PubMed ID: 1803990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities.
    Oki T; Tenmyo O; Hirano M; Tomatsu K; Kamei H
    J Antibiot (Tokyo); 1990 Jul; 43(7):763-70. PubMed ID: 2167304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.